{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:42:14Z","timestamp":1792435334661,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1910B"],"award-info":[{"award-number":["01GM1910B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390874280"],"award-info":[{"award-number":["390874280"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390939984"],"award-info":[{"award-number":["390939984"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC-2189"],"award-info":[{"award-number":["EXC-2189"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RESIST \u2013 EXC 2155"],"award-info":[{"award-number":["RESIST \u2013 EXC 2155"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1160\/2_B5"],"award-info":[{"award-number":["SFB1160\/2_B5"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["GR1617\/14-1\/iPAD"],"award-info":[{"award-number":["GR1617\/14-1\/iPAD"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.conctc.2022.101008","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T04:27:02Z","timestamp":1663993622000},"page":"101008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-033X","authenticated-orcid":false,"given":"M\u00e1t\u00e9","family":"Krausz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6444-9208","authenticated-orcid":false,"given":"Annette","family":"Uhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina Caroline","family":"Rump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-1589","authenticated-orcid":false,"given":"Gabriele","family":"Ihorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigune","family":"Goldacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-2945","authenticated-orcid":false,"given":"Georgios","family":"Sogkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Posadas-Cantera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fei\u00dft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-0018","authenticated-orcid":false,"given":"Laia","family":"Alsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Dybedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Recher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2022.101008_bib1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"New genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.conctc.2022.101008_bib2","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.4049\/jimmunol.174.8.4803","article-title":"Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells","volume":"174","author":"Mead","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.159.1.144","article-title":"Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression","volume":"159","author":"Chuang","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.conctc.2022.101008_bib5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.conctc.2022.101008_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.conctc.2022.101008_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1136\/gutjnl-2014-308541","article-title":"Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4","volume":"64","author":"Zeissig","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.conctc.2022.101008_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood.2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.conctc.2022.101008_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.conctc.2022.101008_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exomesequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671755","article-title":"Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management","volume":"12","author":"L\u00f3pez-Nevado","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4\u2013insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02012","article-title":"Increased risk for malignancies in 131 affected CTLA4 mutation carriers","volume":"9","author":"Egg","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood-2016-10-745174","article-title":"Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations","volume":"129","author":"Hou","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.conctc.2022.101008_bib15","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jaip.2019.04.011","article-title":"Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review","volume":"7","author":"Habibi","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.conctc.2022.101008_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.conctc.2022.101008_bib17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/imt.14.84","article-title":"mTOR signaling, Tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.conctc.2022.101008_bib18","series-title":"Orencia: EPAR - Product Information","year":"2020"},{"key":"10.1016\/j.conctc.2022.101008_bib19","series-title":"Orencia (Abatacept): an Overview of Orencia and Why it Is Authorised in the EU","year":"2019"},{"key":"10.1016\/j.conctc.2022.101008_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2015.08.036","article-title":"Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4","volume":"137","author":"Lee","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.41055","article-title":"Abatacept in early diffuse cutaneous systemic sclerosis: results of a phase II investigator\u2010initiated, multicenter, double\u2010blind, randomized, placebo\u2010controlled trial","volume":"72","author":"Khanna","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.conctc.2022.101008_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaip.2020.10.028","article-title":"Abatacept use is associated with steroid dose reduction and improvement in fatigue and CD4-dysregulation in CVID patients with interstitial lung disease","volume":"9","author":"von Spee-Mayer","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.conctc.2022.101008_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02959944","article-title":"Der deutsche SF-36 Health Survey \u00dcbersetzung und psychometrische Testung eines krankheits\u00fcbergreifenden Instruments zur Erfassung der gesundheitsbezogenen Lebensqualit\u00e4t","volume":"3","author":"Bullinger","year":"1995","journal-title":"Z. Gesundh. Wiss."},{"key":"10.1016\/j.conctc.2022.101008_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.rmed.2009.09.006","article-title":"The SF-36 and SGRQ: validity and first look at minimum important differences in IPF","volume":"104","author":"Swigris","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.conctc.2022.101008_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2006-932661","article-title":"Validierung der Deutschen Version (Kompetenznetz \u201eChronisch entz\u00fcndliche Darmerkrankungen\u201d) des Inflammatory Bowel Disease Questionnaire IBDQ-D TT - validation of the German Version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD","volume":"56","author":"Janke","year":"2006","journal-title":"Psychother Psych Med"},{"key":"10.1016\/j.conctc.2022.101008_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-2005-858579","article-title":"Lebensqualit\u00e4t bei chronisch entz\u00fcndlichen Darmerkrankungen (CED): die deutsche Version des Inflammatory Bowel Disease Questionnaire (IBDQ-D) zur krankheitsspezifischen Lebensqualit\u00e4tsmessung \u2013 erste Anwendung und Vergleich mit anderen internationalen Fas","volume":"67","author":"Janke","year":"2005","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.conctc.2022.101008_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2004-812835","article-title":"Validation of the inflammatory Bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis","volume":"42","author":"H\u00e4user","year":"2004","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.conctc.2022.101008_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/neuonc\/nox029","article-title":"The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria","volume":"19","author":"Nayak","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.conctc.2022.101008_bib29","series-title":"Recommentdations Related to Contraception and Pregnancy Testing in Clinical Trials","year":"2014"},{"key":"10.1016\/j.conctc.2022.101008_bib30","article-title":"Therapeutic options for CTLA-4 insufficiency","author":"Egg","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.conctc.2022.101008_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCG.0b013e3182a4e0ec","article-title":"Abatacept: a new treatment option for refractory adult autoimmune enteropathy","volume":"48","author":"Gupta","year":"2014","journal-title":"J. Clin. Gastroenterol."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865422001259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865422001259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:06:26Z","timestamp":1762520786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865422001259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":31,"alternative-id":["S2451865422001259"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2022.101008","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2022.101008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101008"}}